As payers grapple with accelerating pharmacy spending, HealthScape Advisors is adding independent pharmacy benefit management capabilities with the acquisition of PayerAlly.

The transaction brings a disruptive, analytics-driven consultancy into a Blackstone and Audax Private Equity-backed platform focused on payer strategy, deepening its ability to advise on total cost of care.

PayerAlly was launched in 2022 as an independent challenger in the pharmacy cost management advisory space, with offices in Orlando and New York.

The firm provides PBM procurement and oversight, specialty pharmacy and infusion strategy, medical drug management, and clinical pharmacy analytics.

Its services help health plans and self-insured employers navigate PBM contracts, audit vendor performance, and integrate drug spending into broader medical cost strategies.

PayerAlly will continue to operate as a standalone division within HealthScape, with co-founders Will McHugh, Bill Guerci, and Kerri Tanner managing the business.

The structure preserves the consultancy’s independent focus while giving it access to HealthScape’s technology infrastructure, data analytics, and deep payer relationships.

Together, the combined organization aims to deliver more integrated solutions for high-cost specialty drugs, rebate optimization, and PBM program design.

HealthScape Advisors is a payer-focused advisory firm within the Chartis group of healthcare brands.

Chartis, backed by Blackstone and Audax Private Equity, fields over 1,450 professionals and serves more than 1,900 organizations annually across the healthcare spectrum.

The acquisition builds on HealthScape’s existing strategy to help health plans, ancillary organizations, and investors manage medical and pharmacy cost trends through data-driven, total cost-of-care approaches.